ReviewMedicine2025
Intermediate metastatic risk lipomatous solitary fibrous tumor of the thigh (previously known as hemangiopericytoma): A rare case report with a literature review.
Review in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
rationaleSolitary fibrous tumor (SFT) is a rare mesenchymal tumor, which can arise at any anatomical location and exhibit a wide variety of histopathological characteristics. Lipomatous solitary fibrous tumor (LSFT) is a rare variant of SFT characterized by hemangiopericytoma-like vascular areas with a varying amount of adipocytic tissue. LSFT can be misdiagnosed with other tumors such as liposarcoma which can lead to unnecessary overtreatment for patients. PATIENT CONCERNS: A 48-year-old man presented to the hospital clinic with a painless swelling located on the medial area of the upper thigh near the femoral artery, he has not seen any change in its size since he has noticed it a year ago. DIAGNOSES: Histological examination confirmed LSFT with an intermediate risk of metastasis.
interventionsThree-dimensional imaging technology with intravenous injection of contrast material was made and revealed a mass with well-vascularity supplied from the deep femoral artery. The lesion was excised and showed an intramuscular well-circumscribed encapsulated mass. OUTCOMES: The pathological findings LSFT with intermediate metastatic risk, and he is scheduled to receive radiotherapy for one and a half months. The majority of SFTs display benign histological characteristics and typically follow a slow clinical progression, leading to a favorable prognosis. To date, fewer than 20 cases of malignant LSFT have been documented. In our case, we utilized a recent tumor classification model that evaluates the metastatic potential of SFTs, and long-term follow-up is necessary because there is a chance of aggressive behavior. LESSONS: LSFTs are usually found incidentally and often present as painless, movable masses. Even though they mostly follow a benign course, long-term follow-up is essential due to the possibility of turning malignant.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.